Blue Jay CollaborativePatient Services Consulting
What we offer

Services built around your patient strategy

Flexible engagements that help pharma and biotech reach more patients, earn trust with patients and caregivers, and show what patient support returns to the business.
How we help

Blue Jay service offerings

Choose a single service or combine several — every engagement is shaped around your goals and your patients.

Discuss the Services
01

Strategy Assessment & Roadmap

Review goals and current support, find what’s misaligned or missing, and deliver a prioritized roadmap.

02

Program Evaluation

Define the outcomes that matter and a tracking and reporting system to show what programs deliver.

03

Patient Education Guidance

Evidence-based guidance on making patient education accessible to all.

04

Advocacy Partnerships

Identify the advocacy organizations that best know patients and build lasting partnerships.

05

Patient Barriers

Map how cost, access and life circumstances affect patients — and where barriers can be removed.

06

Clinical Trial Enrollment

Identify the fears that keep patients from enrolling and address them in outreach and materials.

07

Fractional Leadership

Part-time or interim patient services leadership, or ongoing leadership support post engagement.

08

Speaking & Facilitation

Sessions, panels and talks that bring the patient perspective to leaders, boards and conferences.

How we work

A clear path from insight to impact

1 · Understand priorities

We start with your business goals and a clear picture of the patient support you offer today.

2 · Research the experience

Research on the patient experience highlights the gaps — and the biggest opportunities.

3 · Roadmap & measure

You get a prioritized plan, with measurement built in from day one.

Service FAQs

Questions about working together

Still unsure which service fits? A short conversation usually makes it clear.

Yes. Many engagements start with a Strategy Assessment & Roadmap and then move into Program Evaluation, Patient Barriers or Fractional Leadership based on what the roadmap shows.

Our deepest experience is in oncology, blood and marrow transplant and cell therapy, and the framework applies across the drug lifecycle and other complex conditions.

It depends on scope. An assessment and roadmap is a focused project; fractional leadership can be interim or ongoing. We agree on timing together at the start.

Yes — any healthcare organization that wants patient support to drive access, equity and business results is a good fit.

A conversation about your goals and current patient support. From there we’ll suggest the right starting point.

Not sure where to start?

A conversation is the easiest first step. We’ll help you figure out which service fits where you are today.
Scroll to Top